retatrutide israel Emerging Weight Loss Injectables Retatrutide Europe | EU Research

Description

While Foundayos trial results dont seem as compelling as oral Wegovy or the injectable GLP-1s, its still a key addition to the GLP-1 lineup

(2025) doi: 10.1001/jamapsychiatry.2024.4789 Summary Keywords alcohol use, All of Us cohort, cocaine dependence, drug repurposing, GLP-1 receptor agonists, nicotine dependence, opioid use, substance use disorders Citation Abegaz TM, Ahmed M, Bhagavathula AS and Frietze G (2026) Association between GLP-1 receptor agonist use and substance use disorders among individuals with type 2 diabetes or obesity: a nested case-control study in the All of Us research program

Chen C, Zhou R, Fu F, Xiao J (2023) Postmarket safety profile of suicide/self-injury for GLP-1 receptor agonist: a real-world pharmacovigilance analysis

Your clinician will work with you to develop the right long-term plan

Whether you're learning about peptide reconstitution, comparing concentrations or trying to understand syringe measurements a reliable Retatrutide calculator can make the process significantly easier